跳至主要内容
临床试验/NCT05339724
NCT05339724已完成不适用

Platelets: A Neglected Cell in Cystic Fibrosis Lung Inflammation

Mersin Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 53 人开始时间: 2022年4月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
53
试验地点
1
主要终点
Platelet levels and mean platelet volume in acute pulmonary infection in patients with cystic fibrosis

研究概览

简要总结

Cystic fibrosis (CF) is a chronic multiorgan disorder caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene. Chronic airway infection by bacterial pathogens accounts for the progressive, suppurative pulmonary disease that leads to significant morbidity and mortality in patients with CF. Neutrophil recruitment to the lungs accounts the most important contributor to pulmonary destruction. However, there is evidence that platelets may also have an important role in the pathogenesis of inflammation. To our knowledge, there is few information in platelet levels in patients with cystic fibrosis during pulmonary exacerbation, chronic airway colonization and when stable.

详细描述

Airway inflammation in CF is predominantly neutrophilic in nature with increased concentrations of pro-inflammatory mediators include TNF-α, IL-1β, IL-6, IL-8, IL-17, IL-33, GM-CSF and G-CSF. In addition, other cell types including macrophages and T-lymphocytes are expressed by CFTR and contribute to the CF inflammatory response.

Researches have indicated that platelets may also have a significant contribution to the inflammation. Platelet depletion or antiplatelet therapies attenuate injury and mortality in animal models of acute lung injury. More importantly, CFTR expression has been shown on human platelets. Recent data suggests that CF patients have an increase in circulating activated platelets and platelet reactivity.

Taken together, these observations support a potentially important role of platelets in regulating lung inflammation in CF. However, there are few studies examine platelet and lung inflammation interraction in patients with CF. Therefore we aimed to investigate platelet count (PC) and mean platelet volume (MPV) levels in various conditions in our CF patients.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
12 Months 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • All regularly followed cystic fibrosis patients with clinical and laboratory results could be obtained from medical charts.

排除标准

  • 未提供

结局指标

主要结局

Platelet levels and mean platelet volume in acute pulmonary infection in patients with cystic fibrosis

时间窗: 2 weeks

Elevated platelet level count (x103/uL) and increased mean platelet volume (fl) during acute pulmonary exacerbation in cystic fibrosis patients

次要结局

未报告次要终点

研究者

发起方
Mersin Training and Research Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Ali Özdemir

Assoc Prof

Mersin Training and Research Hospital

研究点 (1)

Loading locations...

相似试验